A safe and sustainable society and environment are the two pillars on which our future stands, and both have to be continuously supported and protected by transparent, long-sighted and science-based regulation that is shared by all actors involved. BIORIMA is contributing to these ongoing new regulatory needs by developing novel methodologies that help us to obtain the knowledge and tools to manage possible risks associated with emerging new materials, such as nano-biomaterials (NBM), when used in medical applications.
The Nanosafety Community met virtually for their 10th International Conference on Nanotoxicology - Nanotox between 20th to 22nd April 2021. This year's conference has been jointly organised by by three leading EU Horizon 2020 Projects, BIORIMA, GRACIOUS, and PATROLS - focusing on the development of novel tools for evaluating human and environmental hazard, and strategies for nanomaterial characterization, grouping, and read-across for risk analysis.
Welcome to the third BIORIMA newsletter and the first one for 2021, giving you a short overview about the project's achievements since the last edition and the plans for its final year.
In the current COVID-19 climate, the project is identifying science and technology solutions across BIORIMA which could be rapidly developed and deployed to reduce exposure and hazards posed by COVID-19. We are now identifying partners outside BIORIMA (including other EU-funded projects) to further promote these initiatives. Overall, we aim to bring the BIORIMA risk management framework for safe NBMs to bear on the present and future pandemics.
This year's Annual Meeting of BIORIMA was organized as a virtual meeting including a dedicated session on "BIORIMA response to COVID-19".
In these times, when COVID-19 is still challenging the world, we all have opportunities to step back and see things from a different perspective. And indeed, many of us are experiencing this pandemic not only as a challenge, but also as a time for change and renewal, be it on the political, socioeconomic or personal level, and in particular related to our existing safety and health care systems.
This forum is a discussion platform for relevant stakeholders and end-users to reach out to the project, to directly contact the expert, and to share and discuss your views and requirements.
Successful BIORIMA Consortium Meeting held in Rome, Italy.
The BIORIMA project was part of the joint NanoSafety Cluster booth at the 9th edition of EuroNanoForum.
In the light of increasing regulatory demands on the use of medical devices (MD) and advanced therapeutic medicinal products (ATMP), the EU funded BIORIMA project has taken a lead in developing an integrated risk management framework for the safe handling of nano-biomaterials (NBM) used in these medical applications. For the first time, it will be possible to assess and manage various risks that may arise from manufacturing and use of these novel materials along their life cycle and beyond clinical risks.